Skip to main content
Journal of Stroke logoLink to Journal of Stroke
letter
. 2014 Sep 30;16(3):202–204. doi: 10.5853/jos.2014.16.3.202

Cerebellar Hemorrhage in a Patient during the Convalescent Phase of Dengue Fever

Ángel Vargas-Sánchez a, Erwin Chiquete b, Patricia Gutiérrez-Plascencia a, Víctor Castañeda-Moreno a, Denisse Alfaro-Castellanos a, Patricia Paredes-Casillas c, José L Ruiz-Sandovala a,d,
PMCID: PMC4200593  PMID: 25328880

Dear Sir:

Dengue fever is the most common arboviral infection, accounting for an estimated 100 million cases per year worldwide and representing the most important arthropod-borne viral disease in terms of morbidity and mortality.1 This disease is principally transmitted by Aedes aegypti and Aedes albopictus mosquitoes and mainly affects populations from the tropical and subtropical regions.2 Clinical presentations of classic dengue fever include acute fever, headache, retroocular pain, skin rash, and muscular and osteoarticular pain.3 A more aggressive presentation of the illness, known as dengue hemorrhagic fever is noted in 40%-70% of dengue fever cases.4 Dengue hemorrhagic fever is characterized by hemorrhagic events and high fever, as well as hepatomegaly and hemodynamic alterations. Dengue shock syndrome-another clinical form of the disease-is defined as hypovolemia secondary to capillary plasma leakage with hemodynamic repercussions.1,4,5

Central nervous system complications of dengue are diverse and include acute encephalitis, acute disseminated encephalomyelitis, transverse myelitis, meningitis, cranial neuropathy, Guillain-Barré syndrome, myositis, and hemorrhagic stroke.1,2,3,4,5,6,7 Here, we report the case of a patient with dengue fever and cerebellar hemorrhage. A literature review was also performed to illustrate the scarcity of cases of hemorrhagic stroke in association with dengue fever.

A 64-year-old woman, with a history of hypertension under optimal control, was diagnosed with dengue fever during the 2010 outbreak in Western Mexico.4 A week after the diagnosis, a nearly complete remission of her symptoms was reported. However, 23 days after diagnosis, the patient arrived in the emergency room of our institution complaining of sudden onset headaches of moderate to severe intensity in the occipital region, vertigo, vomiting, and somnolence. A review of her vital signs showed tachypnea and blood pressure of 138/58 mmHg. During a neurological examination, the patient was found to be drowsy and dysarthric, with symmetric and hyporesponsive pupils, multidirectional nystagmus, and no papilledema. The patient was stabilized in the emergency room and a cranial computed tomography scan was performed. The scan showed cerebellar vermian and supravermian hemorrhages without ventricular drainage or mass effects over the brainstem structures (Figure 1). Magnetic resonance imaging and cerebral angiography excluded other sources of intracerebral hemorrhage, such as aneurysm, arteriovenous malformations, or dural fistulas. At this point, no hematological disturbances were noted (platelet count: 125,000/mL, prothrombin time: 12 seconds, partial thromboplastin time: 28 seconds, and international normalized ratio: 1.02). A serological test result for the presence of IgM dengue antibodies was reported as reactive. The patient improved within a week with conservative management, and she was discharged with minimal cerebellar deficits.

Figure 1.

Figure 1

A computed tomography scan of the head showing a vermian (A) and supravermian (B) cerebellar hematoma.

The symptoms of dengue virus infection differ in severity and characteristics, depending on the age and immunological status of the patient. The symptomatology begins after an incubation period of 3 to 14 days, with an acute febrile state that lasts about a week. In severe presentations such as dengue hemorrhagic fever, increased vascular permeability, thrombocytopenia, fever, and hemorrhagic manifestations may occur, mainly between the third and seventh days of illness.4,5 Central nervous system complications associated with dengue are relatively uncommon, with a reported frequency of around 1%.5 Cam et al.6 reported 5,400 patients with dengue fever, 27 of whom (0.5%) presented with central nervous system involvement, but only one with an intracranial hemorrhage. Intracerebral hemorrhage associated with dengue fever is a rare condition, with less than 15 cases documented in the English literature to date (Table 1). In our review, we documented no gender differences, a wide age range at presentation, prolonged prothrombin time, and thrombocytopenia as common laboratory findings (Table 1). Kumar et al.2 reported three patients with basal ganglia hemorrhage and two with acute subdural hematoma occurring during the convalescent period of dengue fever. In all cases, prolonged prothrombin times were noted along with severe thrombocytopenia and moderate to severe headaches prior to neurological deterioration.2

Table 1.

A literature review of reported cases of intracerebral hemorrhage associated with dengue virus infection as confirmed by serology

graphic file with name jos-16-202-i001.jpg

ICH, Intracerebral hemorrhage; NS, Not specified.

The proposed mechanisms that lead to intracerebral hemorrhage in dengue infections are mostly related to impaired hemostasis: thrombocytopenia, prolonged clotting times with or without disseminated intravascular coagulation, or multiple organ failure and capillary leakage syndrome. Other associated conditions might include direct tissue lesions (encephalitis), vasculopathy, cerebral hypoxia, fluid and electrolyte disturbances, and hepatic and/or renal failure.5,6 A possible cause of the hemorrhage in our patient could be inflammatory vasculopathy. Vessel function is a part of the hemostasis mechanism that has been implicated in the pathogenesis of dengue fever, even in the absence of altered coagulation or platelet count.5,6 In this case, we discarded a hypertensive etiology since the hematoma location was not typical of hypertensive intracerebral hemorrhage, and the blood pressure was always normal and well controlled. However, we cannot exclude that platelet function, rather than count, other non-discernible coagulation disturbances, or chronic vasculopathy associated with hypertension could be a predisposing factor in this case.

Our case illustrates a rare complication of dengue fever, especially because it presented during the convalescent phase of the disease, and without any identifiable association with coagulopathy. Although this issue may be subject to reporting bias, to the best of our knowledge, this case represents the thirteenth reported in the medical literature (Table 1), and the only case with normal coagulation and platelet counts presenting in the convalescent phase of the arboviral infection. When other major causes have been ruled out and before classifying the intracranial hemorrhage as idiopathic, dengue virus infection should be considered in the differential diagnosis in endemic areas or during outbreaks.

Acknowledgments

The authors declare that there are no conflicts of interest. This report was received, reviewed, and approved by the Committee of Ethics of the Hospital Civil de Guadalajara "Fray Antonio Alcalde."

Footnotes

The authors have no financial conflicts of interest.

References

  • 1.De Souza LJ, Martins AL, Paravidini PC, Nogueira RM, Gicovate Neto C, et al. Hemorrhagic encephalopathy in dengue shock syndrome: a case report. Braz J Infect Dis. 2005;9:257–261. doi: 10.1590/s1413-86702005000300009. [DOI] [PubMed] [Google Scholar]
  • 2.Kumar R, Prakash O, Sharma BS. Intracranial hemorrhage in dengue fever: management and outcome. A series of 5 cases and review of the literature. Surg Neurol. 2009;72:429–433. doi: 10.1016/j.surneu.2009.01.021. [DOI] [PubMed] [Google Scholar]
  • 3.Kumar J, Kumar A, Gupta S, Jain D. Dengue hemorrhagic fever: an unusual cause of intracranial hemorrhage. J Neurol Neurosurg Psychiatry. 2007;78:253. doi: 10.1136/jnnp.2006.100909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Fajardo-Dolci G, Meljem-Moctezuma J, Vicente-González E, Venegas-Páez FV, Mazón-González B, Aguirre-Gas HG. Dengue fever in Mexico. Knowledge for improving the quality of health. Rev Med Inst Mex Seguro Soc. 2012;50:631–639. [PubMed] [Google Scholar]
  • 5.Puccioni-Sohler M, Orsini M, Soares CN. Dengue: a new challenge for neurology. Neurol Int. 2012;4:e15. doi: 10.4081/ni.2012.e15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cam BV, Fonsmark L, Hue NB, Phuong NT, Poulsen A, Heegaard ED. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg. 2001;65:848–851. doi: 10.4269/ajtmh.2001.65.848. [DOI] [PubMed] [Google Scholar]
  • 7.Mathew S, Pandian SD. Stroke in patients with dengue. J Stroke Cerebrovasc Dis. 2010;19:253–256. doi: 10.1016/j.jstrokecerebrovasdis.2009.05.003. [DOI] [PubMed] [Google Scholar]
  • 8.Khanna A, Atam V, Gupta A. A case of dengue encephalitis with intracerebral hemorrhage. J Glob Infect Dis. 2011;3:206–207. doi: 10.4103/0974-777X.81707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Assir MZ, Jawa A, Ahmed HI. Expanded dengue syndrome: subacute thyroiditis and intracerebral hemorrhage. BMC Infect Dis. 2012;12:240. doi: 10.1186/1471-2334-12-240. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Stroke are provided here courtesy of Korean Stroke Society

RESOURCES